The Effect of Post-surgical Chlorhexidine Mouth Washing on the Sub-gingival Periodontal Microbiome A Pilot Study
NCT ID: NCT05355740
Last Updated: 2023-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2023-02-03
2024-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Visit 1: After initial screening a case report form (CRF) will be filled, including information regarding general health, medication, demographic, oral and dental information. Participants will be clinically examined and the following data will be collected prior to surgery: microbial collection, Plaque score (PS) , probing pocket depth (PPD), bleeding on probing (BOP) at selected non-surgical and surgical teeth. Surgery will be performed followed by discharge with a bottle of chlorhexidine mouthwash and written instructions on its usage. Visit 2: Ten days after surgery sutures will be removed and collected for microbial examination. Microbial collection will be performed at non-surgical and surgical sites. Adverse events will be recorded and participants will be discharged from the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Effect of Chlorhexidine Mouthwash After Periodontal Surgery
NCT04223076
The Use of Chlorhexidine and a Probiotic Lozenge in the Nonsurgical Therapy of Periodontitis
NCT05548361
Evaluation and Comparison of the Efficacy of Triphala Mouthwash and 0.2% Chlorhexidine
NCT01900535
Hypochlorous Acid Mouthwash, Oral Bacteria, and Staphylococcus Aureus
NCT05372835
Efficacy of Two Commercially Available Chlorhexidine Mouthrinses Non-alcohol Base
NCT01580943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Corsodyl
Corsodyl (a chlorhexidine mouthwash) will be used to rinse the mouth for one minute with 10 ml twice daily during ten days after oral surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
* Scheduled for periodontal/dental surgery without pre- and/or post-surgical antibiotic therapy
Exclusion Criteria
* Pregnancy and breast-feeding
* Chronic medications that are known to affect periodontal tissues such as Ca channel blockers and phenytoin
* Antibiotic therapy within the previous 6 weeks
* Mouthwash therapy within the previous 2 weeks
* Known allergy to CM or any of its constituents
* Smoking \>10 cigarettes/day
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jacob Horwitz MD
Director-Graduate Program in Periodontology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacob Horwitz, DMD
Role: PRINCIPAL_INVESTIGATOR
Rambam Health Care Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rambam Health Care Campus
Haifa, , Israel
Rambam Health Care Campus
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jacob Horwitz, DMD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0694-21-RMB CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.